Axillary lymph node dissection is not routinely indicated in patients with sentinel lymph node residual micrometastases following neoadjuvant systemic therapy - 10/04/26
, Kefah Mokbel bAbstract |
Background |
The clinical relevance of residual micrometastatic nodal disease (ypN1mi) detected in the sentinel lymph node (SLN) or following targeted axillary dissection (TAD) after neoadjuvant systemic therapy (NST) remains uncertain, particularly regarding the need for completion axillary lymph node dissection (cALND).
Methods |
This narrative review summarizes evidence from registry-based and international cohort studies evaluating axillary recurrence and oncological outcomes in patients with ypN1mi managed with or without cALND after NST.
Results |
Analyses from the SEER registry and the OPBC-07/microNAC cohort demonstrate a low incidence of axillary recurrence and no significant differences in oncological outcomes between SLNB alone and cALND. In subgroup analyses of triple-negative breast cancer, microNAC reported lower axillary recurrence rates with cALND; however, no difference in invasive recurrence was observed between groups.
Conclusions |
Routine cALND appears unnecessary in most patients with ypN1mi after NST. Future studies should evaluate whether regional nodal irradiation can also be safely omitted.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Routine ALND does not improve survival in patients with SLN micrometastases after NST. |
• | Omission of ALND is associated with very low axillary recurrence in ypN1mi disease. |
• | Axillary radiotherapy provides equivalent regional control with less morbidity than ALND. |
• | Prospective trials are needed to determine whether RNI can be safely omitted in ypN1mi. |
Keywords : Breast cancer, Axillary lymph node dissection, Sentinel lymph node micrometastases, Neoadjuvant systemic therapy, Axillary radiotherapy, Targeted axillary dissection, de-escalation
Plan
Vol 256
Article 116901- juin 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
